dr. camidge on low testosterone in patients with alk-positive lung cancer
Published 11 years ago • 309 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:37
dr. camidge on the alex trial in patients with alk nsclc
-
1:51
dr. camidge discusses treatment of patients with alk nsclc
-
1:28
dr. camidge on ap26113 in patients with advanced malignancies
-
1:28
dr. camidge on met as a target in lung cancer
-
3:21
phase 1 study of crizotinib in patients with alk-positive non-small cell lung cancer
-
1:00
dr. camidge on phase i study with azd9291 in nsclc
-
1:00
dr. camidge discusses unmet needs in alk lung cancer
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
1:19
dr. ross camidge discusses resequencing lung cancer
-
1:15:17
dr ross camidge 1:3:20
-
1:58
dr. camidge on mechanisms of resistance to tkis in nsclc
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
1:09
dr. camidge on crizotinib as a ros1 inhibitor in nsclc
-
1:01
what is an alk-positive cancer?
-
42:31
alk positive lung cancer in 2023 and beyond: thinking outside the box with dr. alice shaw
-
41:39
alk positive summit 2022: hope & alk positive lung cancer presented by dr. ross camidge
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
8:25
alk-positive lung cancer
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing